Network·Hedge Fund
📍 NEW YORK, NY
SEC CRD #802-126024
Home Home The Firm Team Portfolio News and Insights Contact Us LP Login Home The Firm Team Portfolio News and Insights Contact Us LP Login Building Enduring Businesses in Pharma Services We partner with technology-enabled, EBITDA-positive pharma services businesses driving innovation in manufacturing and clinical trial services Learn More Investment Themes Outsourced Complex Biomanufacturing Our companies manufacture and support the supply chain for complex medicines—including biologics, bioconjugates, cell therapies, and peptides—delivering science, scale, and quality to the life sciences industry and patients. Outsourced Biologics Manufacturing Learn More Outsourced Cell Therapy Manufacturing Learn More Outsourced Clinical Trial Services We back companies modernizing the clinical trials workflow through improved site operations, smarter patient recruitment, increased participant access, and purpose-built technology. Clinical Trial Site Network Learn More Clinical Trial Site Network Learn More Digitized Pathology Platform for Clinical Trials Learn More Digital Transformation Lab Procurement Platform and Marketplace for R D Learn More Direct-to-Patient Platform for Pharma Learn More News Insights Latest activity from Biospring and our portfolio May 27, 2026 Biospring Hosts Kiniciti Webinar on iPSCs with Cellistic and Ncardia More May 07, 2026 Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics More February 27, 2026 Webinar: Tr
New York
CFO
📞 (347) 902-9377
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
NEW YORK, NY
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.